<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Estimating the risk of valvular procedures</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Estimating the risk of valvular procedures</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Estimating the risk of valvular procedures</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Catherine M Otto, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gabriel S Aldea, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Edward Verrier, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bernard J Gersh, MB, ChB, DPhil, FRCP, MACC</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan B Yeon, MD, JD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 02, 2021.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>A variety of factors affect mortality and morbidity associated with surgical or transcatheter interventions for valvular heart disease. These factors can be grouped as patient related, procedure related, and operator and medical center related [<a href="#rid1">1-5</a>]. An expert consensus statement from several professional societies recommended evaluation and treatment at a primary or comprehensive valve center to improve patient outcomes, with choice of center based on the patient’s risk and planned procedure [<a href="#rid6">6</a>].</p><p>The most effective way of stratifying operative risk related to patient factors is by using one of the available validated risk stratification models. The risk models are helpful in the evaluation and counseling of individual patients and planning perioperative care but are subject to significant limitations. Models have been developed to estimate risk of in-hospital mortality and complications associated with valve surgery with or without coronary artery bypass graft surgery (CABG).</p><p>Risk stratification models for valvular surgery and transcatheter procedures will be reviewed here [<a href="#rid7">7-12</a>]. Other considerations in preoperative assessment of potential cardiac surgery candidates are discussed separately. (See  <a class="medical medical_review" href="/d/html/1561.html" rel="external">"Operative mortality after coronary artery bypass graft surgery"</a> and  <a class="medical medical_review" href="/d/html/8154.html" rel="external">"Indications for valve replacement for high gradient aortic stenosis in adults"</a> and  <a class="medical medical_review" href="/d/html/8160.html" rel="external">"Natural history and management of chronic aortic regurgitation in adults"</a> and  <a class="medical medical_review" href="/d/html/8140.html" rel="external">"Surgical and investigational approaches to management of mitral stenosis"</a> and  <a class="medical medical_review" href="/d/html/8138.html" rel="external">"Surgical procedures for severe chronic mitral regurgitation"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">LIMITATIONS</span><span class="headingEndMark"> — </span>Risk stratification models are subject to limitations that may reduce their prognostic value. The models lag behind current outcomes as new technologies and clinical practice evolve. Society of Thoracic Surgeons (STS) and EuroSCORE models have been updated infrequently in processes extending over years. The models estimate risk for only specified procedures (eg, the 2018 STS risk model does not include estimates for concomitant aortic and mitral valve surgery [<a href="#rid13">13</a>]). These include dependence upon incomplete or uncertain clinical variables. The models may not be generalizable to patient populations different from the ones in which they were formulated, and they require revision over time as surgical and perioperative care evolve and as the recognition and impact of clinical variables change.</p><p>In addition, current risk stratification models do not include several variables that may be clinically important. For example, a severely calcified ascending aorta (also known as porcelain aorta, a risk factor for patients undergoing cardiac surgery) and severe mitral annular calcification (a risk factor in patients undergoing mitral surgery (see  <a class="medical medical_review" href="/d/html/116169.html" rel="external">"Management and prognosis of mitral annular calcification", section on 'Mitral valve surgery'</a>)) are each associated with high operative morbidity and mortality but are not included in standard risk models [<a href="#rid14">14-18</a>]. Other clinically important variables that are not included in risk models are difficult to measure, such as frailty, exercise capacity, and nutritional status, as well as other hemodynamic factors such as pulmonary pressures and right ventricular dysfunction. These additional factors are especially important when considering the choice between a surgical or transcatheter valve procedure. Some of these factors may be the determining factor in this decision for specific patients. (See  <a class="medical medical_review" href="/d/html/83110.html" rel="external">"Choice of intervention for severe calcific aortic stenosis"</a>.)</p><p>In addition, risk models for cardiac surgery do not necessarily indicate the risk of newer transcatheter procedures, such as transcatheter aortic valve implantation, that increasingly are effective alternates to conventional surgery [<a href="#rid19">19</a>]. Current guidelines recommend evaluation of patients by a specialized heart valve clinic when valve intervention is needed so that risks and benefits of a surgical versus transcatheter procedure can be discussed by a multidisciplinary team [<a href="#rid20">20,21</a>].</p><p class="headingAnchor" id="H3"><span class="h1">RISK STRATIFICATION MODELS</span></p><p class="headingAnchor" id="H2087646123"><span class="h2">Commonly used models</span><span class="headingEndMark"> — </span>Risk stratification models for hospital mortality following cardiac surgery include the following calculators:</p><p class="bulletIndent1"><span class="glyph">●</span>The STS risk model is the most widely used algorithm and it is continuously updated. The 2018 Society of Thoracic Surgeons (STS) risk models for coronary artery bypass graft surgery (CABG), valve surgery, or both were developed and validated based on data on 774,881 patients operated on during 2002 to 2006 [<a href="#rid13">13,22</a>]. The STS registry includes data from nearly 90 percent of cardiac surgery providers in the United States [<a href="#rid22">22</a>]. The models provide estimates of risk of mortality as well as several nonfatal complications such as stroke, renal failure, and prolonged ventilation. A calculator is available online (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.sts.org%2Fresources%2Frisk-calculator&amp;token=WhUQIRHs99TZxZpKH9Zs5XpIJnGfP4mtHeOSJyyX%2B55Is15OCDqzqmcwEBdNpFLuLX%2FIKry9SmqgjYV18u1aHA%3D%3D&amp;TOPIC_ID=8153" target="_blank">www.sts.org/resources/risk-calculator</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The first EuroSCORE model was developed based upon data from 1995 to stratify risk of in-hospital mortality [<a href="#rid23">23</a>]. This model has been replaced by the 2011 EuroSCORE II model, which was developed based on data from 22,381 patients in 43 countries operated on during May to July 2010 [<a href="#rid24">24</a>]. Overall mortality was 3.9 percent, which is lower than would have been predicted by old risk models (additive predicted 5.8 percent and logistic predicted 7.6 percent). A calculator for the EuroSCORE II is available online (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.euroscore.org%2F&amp;token=%2B0rEyHQ1T7gRoXXx698zAqpHbBd4ctSbc%2Fb4DRd2wUOUGRU1UoZYLtazZMdLoqep&amp;TOPIC_ID=8153" target="_blank">euroscore.org</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The older Ambler risk model for aortic and/or mitral valve surgery with or without concomitant CABG was developed from data from the Society of Cardiothoracic Surgeons of Great Britain and Ireland on 32,839 patients who underwent surgery during 1995 to 2003 [<a href="#rid25">25</a>].</p><p></p><p class="headingAnchor" id="H4"><span class="h2">Use</span><span class="headingEndMark"> — </span>Accurate perioperative risk estimation is required to provide appropriate recommendations and informed consent for individual patients. Comparison of treatment options such as aortic valve surgery versus transcatheter aortic valve implantation requires accurate estimation of expected outcomes. However, the available models have limited applicability since the data on which they are based lag behind rapidly evolving clinical practice. When considering risk estimates from models, the heart team should also consider its own local data for valve surgery and transcatheter valve therapy.</p><p>The prognostic value of the risk models depends upon the population to which the models are applied. Several studies had found that the first version of the EuroSCORE overestimated mortality for various cardiac surgery populations [<a href="#rid26">26-28</a>], including patients undergoing mitral valve surgery [<a href="#rid29">29</a>] and patients undergoing high-risk aortic valve replacement [<a href="#rid30">30-34</a>].</p><p>In patients undergoing aortic valve replacement, the STS model may provide more accurate perioperative risk estimation than the first version of the EuroSCORE [<a href="#rid31">31,33</a>] or the Ambler risk score [<a href="#rid33">33</a>]. In various studies, the first version of the EuroSCORE often overestimated perioperative risk, while the STS model has been observed to under- or overestimate early postoperative mortality [<a href="#rid33">33,35</a>]. The original EuroSCORE and STS score also correlate with long-term postoperative mortality risk, though the relative strengths of these associations vary among series, and other clinical factors (such as presence of renal failure) may have greater predictive value in some groups [<a href="#rid33">33,35</a>]. EuroSCORE II performed similarly to the STS score in a study of patients undergoing mitral valve surgery [<a href="#rid36">36</a>] and had discriminatory power similar to STS score in a study of patients undergoing isolated aortic valve surgery [<a href="#rid37">37</a>].</p><p>Since the 2018 STS and EuroSCORE II risk models provide risk stratification based upon large contemporary databases with adjustment for multiple clinical variables, we recommend their use to estimate operative risk in patients in settings similar to those represented by their respective databases [<a href="#rid38">38</a>].</p><p class="headingAnchor" id="H1779291956"><span class="h2">Clinical implications</span><span class="headingEndMark"> — </span>Risk scores provide a starting point for estimating the surgical mortality and morbidity of valve surgery in an individual patient. This risk estimate may then be adjusted upward or downward depending on additional clinical, anatomic, or hemodynamic factors that are not included in the risk models. Risk estimates are helpful in balancing the risk-benefit ratio of surgical intervention, in optimizing timing of intervention, and for choosing between different interventions (eg, surgical versus transcatheter). In addition, knowledge of specific components of the risk score may suggest ways to reduce risk in an individual patient; for example, performing percutaneous coronary intervention before planned valve surgery, stabilizing the patient with advanced therapies to allow elective (rather than emergency) valve surgery, or optimizing heart failure therapy and hemodynamics prior to intervention.</p><p>An additional limitation is that the risk models don’t account for potential benefits and risks of concomitant procedures, such as coronary artery bypass graft surgery performed at the time of valve surgery or percutaneous coronary intervention performed at the time of transcatheter aortic valve implantation. Other procedures that may be performed at the time of valve surgery include surgical left atrial appendage occlusion and surgical atrial fibrillation ablation.</p><p>In treating younger patients, it is important to consider risk and plans for future interventions (eg, valve in transcatheter heart valve or valve in surgical bioprosthetic valve), which should inform selection of the initial intervention. These issues are particularly important for patients with size or anatomy variations (eg, lower coronary arteries, small sinuses, small aortic annuli, smaller prostheses).</p><p class="headingAnchor" id="H904342619"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/115482.html" rel="external">"Society guideline links: Cardiac valve disease"</a>.)</p><p class="headingAnchor" id="H21325754"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Models have been developed to estimate the risk of in-hospital mortality and complications associated with valve surgery with or without coronary artery bypass graft surgery (CABG). (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Risk stratification models are subject to limitations that may reduce their prognostic value. These include dependence upon incomplete or uncertain clinical variables. In addition, current risk stratification models do not include several variables that may be clinically important. (See <a class="local">'Limitations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Calculators are available online for the 2018 STS model, the EuroSCORE II model, and the Ambler risk model. (See <a class="local">'Risk stratification models'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Since the 2018 STS and EuroSCORE II risk models provide risk stratification based upon large contemporary databases with adjustment for multiple clinical variables, we recommend their use to estimate operative risk in patients in settings similar to those represented by their respective databases. (See <a class="local">'Use'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Chikwe J, Toyoda N, Anyanwu AC, et al. Relation of Mitral Valve Surgery Volume to Repair Rate, Durability, and Survival. J Am Coll Cardiol 2017.</a></li><li><a class="nounderline abstract_t">LaPar DJ, Ailawadi G, Isbell JM, et al. Mitral valve repair rates correlate with surgeon and institutional experience. J Thorac Cardiovasc Surg 2014; 148:995.</a></li><li><a class="nounderline abstract_t">Vassileva CM, McNeely C, Spertus J, et al. Hospital volume, mitral repair rates, and mortality in mitral valve surgery in the elderly: an analysis of US hospitals treating Medicare fee-for-service patients. J Thorac Cardiovasc Surg 2015; 149:762.</a></li><li><a class="nounderline abstract_t">Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346:1128.</a></li><li><a class="nounderline abstract_t">Weiner MM, Hofer I, Lin HM, et al. Relationship among surgical volume, repair quality, and perioperative outcomes for repair of mitral insufficiency in a mitral valve reference center. J Thorac Cardiovasc Surg 2014; 148:2021.</a></li><li><a class="nounderline abstract_t">Nishimura RA, O'Gara PT, Bavaria JE, et al. 2019 AATS/ACC/ASE/SCAI/STS Expert Consensus Systems of Care Document: A Proposal to Optimize Care for Patients With Valvular Heart Disease: A Joint Report of the American Association for Thoracic Surgery, American College of Cardiology, American Society of Echocardiography, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2019; 73:2609.</a></li><li><a class="nounderline abstract_t">Edwards FH, Cohen DJ, O'Brien SM, et al. Development and Validation of a Risk Prediction Model for In-Hospital Mortality After Transcatheter Aortic Valve Replacement. JAMA Cardiol 2016; 1:46.</a></li><li><a class="nounderline abstract_t">Pilgrim T, Franzone A, Stortecky S, et al. Predicting Mortality After Transcatheter Aortic Valve Replacement: External Validation of the Transcatheter Valve Therapy Registry Model. Circ Cardiovasc Interv 2017; 10.</a></li><li><a class="nounderline abstract_t">Greason KL, Eleid MF, Nkomo VT, et al. Predictors of 1-year mortality after transcatheter aortic valve replacement. J Card Surg 2018; 33:243.</a></li><li><a class="nounderline abstract_t">Arsalan M, Weferling M, Hecker F, et al. TAVI risk scoring using established versus new scoring systems: role of the new STS/ACC model. EuroIntervention 2018; 13:1520.</a></li><li><a class="nounderline abstract_t">Kiani S, Kamioka N, Black GB, et al. Development of a Risk Score to Predict New Pacemaker Implantation After Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv 2019; 12:2133.</a></li><li><a class="nounderline abstract_t">Thourani VH, O'Brien SM, Kelly JJ, et al. Development and Application of a Risk Prediction Model for In-Hospital Stroke After Transcatheter Aortic Valve Replacement: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Ann Thorac Surg 2019; 107:1097.</a></li><li><a class="nounderline abstract_t">Shahian DM, Jacobs JP, Badhwar V, et al. The Society of Thoracic Surgeons 2018 Adult Cardiac Surgery Risk Models: Part 1-Background, Design Considerations, and Model Development. Ann Thorac Surg 2018; 105:1411.</a></li><li><a class="nounderline abstract_t">Gillinov AM, Lytle BW, Hoang V, et al. The atherosclerotic aorta at aortic valve replacement: surgical strategies and results. J Thorac Cardiovasc Surg 2000; 120:957.</a></li><li><a class="nounderline abstract_t">Lytwyn J, Stammers AN, Kehler DS, et al. The impact of frailty on functional survival in patients 1 year after cardiac surgery. J Thorac Cardiovasc Surg 2017; 154:1990.</a></li><li><a class="nounderline abstract_t">Afilalo J, Lauck S, Kim DH, et al. Frailty in Older Adults Undergoing Aortic Valve Replacement: The FRAILTY-AVR Study. J Am Coll Cardiol 2017; 70:689.</a></li><li><a class="nounderline abstract_t">Suri RM, Gulack BC, Brennan JM, et al. Outcomes of Patients With Severe Chronic Lung Disease Who Are Undergoing Transcatheter Aortic Valve Replacement. Ann Thorac Surg 2015; 100:2136.</a></li><li><a class="nounderline abstract_t">Thourani VH, Forcillo J, Beohar N, et al. Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER Trial. Ann Thorac Surg 2016; 102:1172.</a></li><li><a class="nounderline abstract_t">Durand E, Borz B, Godin M, et al. Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 2013; 111:891.</a></li><li><a class="nounderline abstract_t">Lancellotti P, Rosenhek R, Pibarot P, et al. ESC Working Group on Valvular Heart Disease position paper--heart valve clinics: organization, structure, and experiences. Eur Heart J 2013; 34:1597.</a></li><li><a class="nounderline abstract_t">Chambers JB, Ray S, Prendergast B, et al. Specialist valve clinics: recommendations from the British Heart Valve Society working group on improving quality in the delivery of care for patients with heart valve disease. Heart 2013; 99:1714.</a></li><li><a class="nounderline abstract_t">O'Brien SM, Feng L, He X, et al. The Society of Thoracic Surgeons 2018 Adult Cardiac Surgery Risk Models: Part 2-Statistical Methods and Results. Ann Thorac Surg 2018; 105:1419.</a></li><li><a class="nounderline abstract_t">Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16:9.</a></li><li><a class="nounderline abstract_t">Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg 2012; 41:734.</a></li><li><a class="nounderline abstract_t">Ambler G, Omar RZ, Royston P, et al. Generic, simple risk stratification model for heart valve surgery. Circulation 2005; 112:224.</a></li><li><a class="nounderline abstract_t">van Gameren M, Kappetein AP, Steyerberg EW, et al. Do we need separate risk stratification models for hospital mortality after heart valve surgery? Ann Thorac Surg 2008; 85:921.</a></li><li><a class="nounderline abstract_t">Nissinen J, Biancari F, Wistbacka JO, et al. Is it possible to improve the accuracy of EuroSCORE? Eur J Cardiothorac Surg 2009; 36:799.</a></li><li><a class="nounderline abstract_t">Bhatti F, Grayson AD, Grotte G, et al. The logistic EuroSCORE in cardiac surgery: how well does it predict operative risk? Heart 2006; 92:1817.</a></li><li><a class="nounderline abstract_t">Kaartama T, Heikkinen L, Vento A. An evaluation of mitral valve procedures using the European system for cardiac operative risk evaluation. Scand J Surg 2008; 97:254.</a></li><li><a class="nounderline abstract_t">Grossi EA, Schwartz CF, Yu PJ, et al. High-risk aortic valve replacement: are the outcomes as bad as predicted? Ann Thorac Surg 2008; 85:102.</a></li><li><a class="nounderline abstract_t">Wendt D, Osswald BR, Kayser K, et al. Society of Thoracic Surgeons score is superior to the EuroSCORE determining mortality in high risk patients undergoing isolated aortic valve replacement. Ann Thorac Surg 2009; 88:468.</a></li><li><a class="nounderline abstract_t">Osswald BR, Gegouskov V, Badowski-Zyla D, et al. Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J 2009; 30:74.</a></li><li><a class="nounderline abstract_t">Dewey TM, Brown D, Ryan WH, et al. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008; 135:180.</a></li><li><a class="nounderline abstract_t">Kalavrouziotis D, Li D, Buth KJ, Légaré JF. The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is not appropriate for withholding surgery in high-risk patients with aortic stenosis: a retrospective cohort study. J Cardiothorac Surg 2009; 4:32.</a></li><li><a class="nounderline abstract_t">Ben-Dor I, Pichard AD, Gonzalez MA, et al. Correlates and causes of death in patients with severe symptomatic aortic stenosis who are not eligible to participate in a clinical trial of transcatheter aortic valve implantation. Circulation 2010; 122:S37.</a></li><li><a class="nounderline abstract_t">Barili F, Pacini D, Grossi C, et al. Reliability of new scores in predicting perioperative mortality after mitral valve surgery. J Thorac Cardiovasc Surg 2014; 147:1008.</a></li><li><a class="nounderline abstract_t">Barili F, Pacini D, Capo A, et al. Reliability of new scores in predicting perioperative mortality after isolated aortic valve surgery: a comparison with the society of thoracic surgeons score and logistic EuroSCORE. Ann Thorac Surg 2013; 95:1539.</a></li><li><a class="nounderline abstract_t">Vahanian A, Otto CM. Risk stratification of patients with aortic stenosis. Eur Heart J 2010; 31:416.</a></li></ol></div><div id="topicVersionRevision">Topic 8153 Version 20.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28476349" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Relation of Mitral Valve Surgery Volume to Repair Rate, Durability, and Survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25048633" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Mitral valve repair rates correlate with surgeon and institutional experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25439776" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Hospital volume, mitral repair rates, and mortality in mitral valve surgery in the elderly: an analysis of US hospitals treating Medicare fee-for-service patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11948273" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Hospital volume and surgical mortality in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24836989" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Relationship among surgical volume, repair quality, and perioperative outcomes for repair of mitral insufficiency in a mitral valve reference center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31010719" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : 2019 AATS/ACC/ASE/SCAI/STS Expert Consensus Systems of Care Document: A Proposal to Optimize Care for Patients With Valvular Heart Disease: A Joint Report of the American Association for Thoracic Surgery, American College of Cardiology, American Society of Echocardiography, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27437653" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Development and Validation of a Risk Prediction Model for In-Hospital Mortality After Transcatheter Aortic Valve Replacement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29127116" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Predicting Mortality After Transcatheter Aortic Valve Replacement: External Validation of the Transcatheter Valve Therapy Registry Model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29654615" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Predictors of 1-year mortality after transcatheter aortic valve replacement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28994653" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : TAVI risk scoring using established versus new scoring systems: role of the new STS/ACC model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31699374" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Development of a Risk Score to Predict New Pacemaker Implantation After Transcatheter Aortic Valve Replacement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30529671" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Development and Application of a Risk Prediction Model for In-Hospital Stroke After Transcatheter Aortic Valve Replacement: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29577925" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The Society of Thoracic Surgeons 2018 Adult Cardiac Surgery Risk Models: Part 1-Background, Design Considerations, and Model Development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11044322" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The atherosclerotic aorta at aortic valve replacement: surgical strategies and results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28734627" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The impact of frailty on functional survival in patients 1 year after cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28693934" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Frailty in Older Adults Undergoing Aortic Valve Replacement: The FRAILTY-AVR Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26330010" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Outcomes of Patients With Severe Chronic Lung Disease Who Are Undergoing Transcatheter Aortic Valve Replacement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27592092" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23337835" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23293304" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : ESC Working Group on Valvular Heart Disease position paper--heart valve clinics: organization, structure, and experiences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23532202" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Specialist valve clinics: recommendations from the British Heart Valve Society working group on improving quality in the delivery of care for patients with heart valve disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29577924" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The Society of Thoracic Surgeons 2018 Adult Cardiac Surgery Risk Models: Part 2-Statistical Methods and Results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10456395" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : European system for cardiac operative risk evaluation (EuroSCORE).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22378855" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : EuroSCORE II.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15998680" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Generic, simple risk stratification model for heart valve surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18291172" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Do we need separate risk stratification models for hospital mortality after heart valve surgery?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19523840" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Is it possible to improve the accuracy of EuroSCORE?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16547206" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The logistic EuroSCORE in cardiac surgery: how well does it predict operative risk?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18812276" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : An evaluation of mitral valve procedures using the European system for cardiac operative risk evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18154791" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : High-risk aortic valve replacement: are the outcomes as bad as predicted?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19632395" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Society of Thoracic Surgeons score is superior to the EuroSCORE determining mortality in high risk patients undergoing isolated aortic valve replacement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19033261" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18179938" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19602289" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is not appropriate for withholding surgery in high-risk patients with aortic stenosis: a retrospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20837923" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Correlates and causes of death in patients with severe symptomatic aortic stenosis who are not eligible to participate in a clinical trial of transcatheter aortic valve implantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23993032" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Reliability of new scores in predicting perioperative mortality after mitral valve surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23473650" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Reliability of new scores in predicting perioperative mortality after isolated aortic valve surgery: a comparison with the society of thoracic surgeons score and logistic EuroSCORE.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20047994" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Risk stratification of patients with aortic stenosis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
